Shinya Okazaki

Summary

Affiliation: Juntendo University School of Medicine
Country: Japan

Publications

  1. ncbi Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study
    Shinya Okazaki
    Department of Cardiology, Juntendo University School of Medicine, 2 1 1 Hongo, Bunkyo ku Tokyo 113 8421 Japan
    Circulation 110:1061-8. 2004
  2. ncbi Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting
    Kazunori Shimada
    Department of Cardiology, Juntendo University School of Medicine, 2 1 1 Hongo Bunkyo, Tokyo 113 8421, Japan
    Int J Cardiol 94:87-92. 2004
  3. ncbi Predictive value of the adipocyte-derived plasma protein adiponectin for restenosis after elective coronary stenting
    Kazunori Shimada
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Jpn Heart J 43:85-91. 2002
  4. ncbi Impact of aspirin treatment on long-term outcome (over 10 years) after percutaneous coronary intervention
    Widi Njaman
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Int Heart J 47:37-45. 2006
  5. ncbi Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo university (ALPS-J)
    Katsumi Miyauchi
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Cardiovasc Drugs Ther 23:409-13. 2009
  6. ncbi Impact of metabolic syndrome among patients with and without diabetes mellitus on long-term outcomes after percutaneous coronary intervention
    Takatoshi Kasai
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Hypertens Res 31:235-41. 2008
  7. ncbi Effectiveness of statin-eluting stent on early inflammatory response and neointimal thickness in a porcine coronary model
    Katsumi Miyauchi
    Department of Cardiovascular Medicine, Juntendo University, Tokyo, Japan
    Circ J 72:832-8. 2008
  8. ncbi Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting
    Tetsuro Miyazaki
    Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan
    Lipids Health Dis 9:122. 2010
  9. ncbi Rationale and design of a study to examine lower targets for low-density lipoprotein-cholesterol and blood pressure in coronary artery disease patients
    Ryozo Nagai
    Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
    Circ J 72:515-20. 2008
  10. ncbi Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials
    Matthias Briel
    Basel Institute for Clinical Epidemiology, University Hospital Basel, Basel, Switzerland
    JAMA 295:2046-56. 2006

Collaborators

Detail Information

Publications11

  1. ncbi Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study
    Shinya Okazaki
    Department of Cardiology, Juntendo University School of Medicine, 2 1 1 Hongo, Bunkyo ku Tokyo 113 8421 Japan
    Circulation 110:1061-8. 2004
    ..The present study investigated the effect of early statin treatment on plaque volume of a nonculprit lesion by serial volumetric intravascular ultrasound in patients with ACS...
  2. ncbi Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting
    Kazunori Shimada
    Department of Cardiology, Juntendo University School of Medicine, 2 1 1 Hongo Bunkyo, Tokyo 113 8421, Japan
    Int J Cardiol 94:87-92. 2004
    ..Monocytes/macrophages and neutrophils are activated by lipopolysaccharide (LPS) via CD14. Endothelial cells and smooth muscle cells are also stimulated by soluble CD14 (sCD14)-LPS complexes...
  3. ncbi Predictive value of the adipocyte-derived plasma protein adiponectin for restenosis after elective coronary stenting
    Kazunori Shimada
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Jpn Heart J 43:85-91. 2002
    ....
  4. ncbi Impact of aspirin treatment on long-term outcome (over 10 years) after percutaneous coronary intervention
    Widi Njaman
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Int Heart J 47:37-45. 2006
    ..Aspirin treatment at the time of PCI significantly reduced the risk of death from any cause and cardiac death. The administration of aspirin had a positive impact on the over 10-year long-term outcomes of patients who underwent PCI...
  5. ncbi Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo university (ALPS-J)
    Katsumi Miyauchi
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Cardiovasc Drugs Ther 23:409-13. 2009
    ..To confirm this hypothesis, a multicenter randomized trial of CCBs treatment with azelnidipine or amlodipine will be conducted in hypertensive CAD patients undergoing elective percutaneous coronary intervention (PCI)...
  6. ncbi Impact of metabolic syndrome among patients with and without diabetes mellitus on long-term outcomes after percutaneous coronary intervention
    Takatoshi Kasai
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Hypertens Res 31:235-41. 2008
    ..87 [1.18-2.96]) were at significant risk for increased cardiac events. In conclusion, the risk of cardiac events is significantly increased in patients with metabolic syndrome following PCI, irrespective of DM...
  7. ncbi Effectiveness of statin-eluting stent on early inflammatory response and neointimal thickness in a porcine coronary model
    Katsumi Miyauchi
    Department of Cardiovascular Medicine, Juntendo University, Tokyo, Japan
    Circ J 72:832-8. 2008
    ..The present study evaluated the ability of stent-based cerivastatin delivery to reduce stent-induced inflammatory responses and adverse effects on endothelial function, and to inhibit neointimal hyperplasia in a porcine coronary model...
  8. ncbi Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting
    Tetsuro Miyazaki
    Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan
    Lipids Health Dis 9:122. 2010
    ..We assessed lipid profiles, plasma CET activity, and in-stent intimal hyperplasia after fenofibrate treatment in patients who underwent elective coronary stenting...
  9. ncbi Rationale and design of a study to examine lower targets for low-density lipoprotein-cholesterol and blood pressure in coronary artery disease patients
    Ryozo Nagai
    Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
    Circ J 72:515-20. 2008
    ....
  10. ncbi Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials
    Matthias Briel
    Basel Institute for Clinical Epidemiology, University Hospital Basel, Basel, Switzerland
    JAMA 295:2046-56. 2006
    ..CONCLUSION: Based on available evidence, initiation of statin therapy within 14 days following onset of ACS does not reduce death, MI, or stroke up to 4 months...
  11. ncbi Long-term (11-year) statin therapy following percutaneous coronary intervention improves clinical outcome and is not associated with increased malignancy
    Takatoshi Kasai
    Department of Cardiology, Juntendo University, School of Medicine, Tokyo, Japan
    Int J Cardiol 114:210-7. 2007
    ..Statins have been proven to reduce cardiac events and mortality. However, there are few studies dealing with the long-term efficacy of statin therapy following percutaneous coronary intervention (PCI)...